CTS-1027 in Interferon-Naive Hepatitis C Patients

NCT00925990 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: ribavirin
DRUG: CTS-1027
DRUG: Placebo for ribavirin

Sponsor

Conatus Pharmaceuticals Inc.